EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice

Constantinos Deltas iD, Gregory Papagregoriou, Stavroula F Louka iD, Apostolos Malatras iD, Frances Flinter, Daniel P Gale, Susie Gear, Oliver Gross iD, Julia Hoefele, Rachel Lennon, Jeffrey H Miner, Alessandra Renieri iD und 2 weitere

Genes · 2023

DOI: 10.3390/genes14091686 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2023. Verfasst von Constantinos Deltas und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Cyprus, Nicosia 2109, Cyprus. Hauptthemen laut MEDLINE: Nephritis, Hereditary, Renal Insufficiency. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CY-Biobank, European Renal Association-European Dialysis and Transplant Association (ERA-EDTA), European Reference Network for the European Rare Kidney Disease Reference Network, ERNnet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial hematuria is a clinical sign of a genetically heterogeneous group of conditions, accompanied by broad inter- and intrafamilial variable expressivity. The most frequent condition is caused by pathogenic (or likely pathogenic) variants in the collagen-IV genes, COL4A3/A4/A5. Pathogenic variants in COL4A5 are responsible for the severe X-linked glomerulopathy, Alport syndrome (AS), while homozygous or compound heterozygous variants in the COL4A3 or the COL4A4 gene cause autosomal recessive AS. AS usually leads to progressive kidney failure before the age of 40-years when left untreated. People who inherit heterozygous COL4A3/A4 variants are at-risk of a slowly progressive form of the disease, starting with microscopic hematuria in early childhood, developing Alport spectrum nephropathy. Sometimes, they are diagnosed with benign familial hematuria, and sometimes with autosomal dominant AS. At diagnosis, they often show thin basement membrane nephropathy, reflecting the uniform thin glomerular basement membrane lesion, inherited as an autosomal dominant condition. On a long follow-up, most patients will retain normal or mildly affected kidney function, while a substantial proportion will develop chronic kidney disease (CKD), even kidney failure at an average age of 55-years. A question that remains unanswered is how to distinguish those patients with AS or with heterozygous COL4A3/A4 variants who will manifest a more aggressive kidney function decline, requiring prompt medical intervention. The hypothesis that a subgroup of patients coinherit additional genetic modifiers that exacerbate their clinical course has been investigated by several researchers. Here, we review all publications that describe the potential role of candidate genetic modifiers in patients and include a summary of studies in AS mouse models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephritis, HereditaryRenal InsufficiencyChild, PreschoolHumansAnimalsMiceMiddle AgedAdultHematuriaCollagen Type IV

Stichwörter der Autor:innen

Alport syndromeCOL4 nephropathiesfocal segmental glomerulosclerosisgenetic modifiersglomerular diseasesthin basement membrane nephropathy

Substanzen

Collagen Type IV

Autor:innen und Institutionen

  • School of Medicine, University of Cyprus, Nicosia 2109, Cyprus.
  • biobank.cy Center of Excellence in Biobanking and Biomedical Research, University of Cyprus, Nicosia 2109, Cyprus.
  • Clinical Genetics Department, Guy's & St Thomas' NHS Foundation Trust, London SE1 9RT, UK.
  • Department of Renal Medicine, University College London, London NW3 2PF, UK.
  • Alport UK, Tetbury GL8 0AW, UK.
  • Clinic for Nephrology and Rheumatology, University Medicine Goettingen, 37075 Goettingen, Germany.

ORCID-Profile: Constantinos Deltas, Stavroula F Louka, Apostolos Malatras, Oliver Gross, Alessandra Renieri, A Neil Turner

Förderung

  • CY-Biobank
  • European Renal Association-European Dialysis and Transplant Association (ERA-EDTA)
  • European Reference Network for the European Rare Kidney Disease Reference Network, ERNnet

Zitieren

APA

Deltas, C., Papagregoriou, G., Louka, S. F., Malatras, A., Flinter, F., Gale, D. P., Gear, S., Gross, O., Hoefele, J., Lennon, R., Miner, J. H., Renieri, A., Savige, J., & Turner, A. N. (2023). Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice. Genes. https://doi.org/10.3390/genes14091686

Vancouver

Deltas C, Papagregoriou G, Louka SF, Malatras A, Flinter F, Gale DP, et al. Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice. Genes. 2023. doi:10.3390/genes14091686

BibTeX
@article{Deltas2023,
  author = {Deltas, Constantinos and Papagregoriou, Gregory and Louka, Stavroula F and Malatras, Apostolos and Flinter, Frances and Gale, Daniel P and Gear, Susie and Gross, Oliver and Hoefele, Julia and Lennon, Rachel and Miner, Jeffrey H and Renieri, Alessandra and Savige, Judy and Turner, A Neil},
  title = {Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14091686}
}
Kostenlos starten →